ENDRA Life Sciences Inc. Warrants
NDRAW
NDRAW was delisted on the 12th of May, 2022.
3 hedge funds and large institutions have $6K invested in ENDRA Life Sciences Inc. Warrants in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
200% more capital invested
Capital invested by funds: $2K → $6K (+$4K)
0% more funds holding
Funds holding: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.24K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$82 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $6K | +$4.24K | +24,908 | +240% |
|
|
2
UBS Group
Zurich,
Switzerland
| – | +$82 | +483 | +393% |
|
NDRAW Hedge Fund Activity: Q2 2020 in Review
3 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences Inc. Warrants (NDRAW) for Q2 2020, worth a combined $6K — up 200% from $2K a quarter earlier.
Fund positioning in NDRAW was balanced in Q2 2020: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $4.24K.
- 3 institutional investors held ENDRA Life Sciences Inc. Warrants (NDRAW) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $6K of ENDRA Life Sciences Inc. Warrants stock for Q2 2020, up 200% quarter-over-quarter.
- 0 funds opened new ENDRA Life Sciences Inc. Warrants positions in Q2 2020 and 0 closed out.
- The largest ENDRA Life Sciences Inc. Warrants buyer in Q2 2020 was Susquehanna International Group, an estimated $4.24K added.
Based on aggregated 13F filings for Q2 2020.